{"product_id":"avecho-biotechnology-ltd-strategy-swot-and-corporate-finance-report","title":"Avecho Biotechnology Ltd - Strategy, SWOT and Corporate Finance Report","description":"\u003cp\u003eAvecho Biotechnology Ltd - Strategy, SWOT and Corporate Finance Report\u003cbr\u003e\nSummary\u003c\/p\u003e\n\n\u003cp\u003eAvecho Biotechnology Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.\u003c\/p\u003e\n\n\u003cp\u003eKey Highlights\u003c\/p\u003e\n\n\u003cp\u003eAvecho Biotechnology Ltd (Avecho), formerly known as Phosphagenics Ltd, is a research-driven biotechnology firm that develops and commercializes human and animal health products. The company’s drug delivery technology tocopheryl phosphate mixture (TPM) is derived from vitamin E using a proprietary and patented process that improves the solubility and oral, dermal, and transdermal adsorption of drugs and nutrients. Avecho’s product portfolio includes daptomycin, diclofenac gel, propofol injection, oxymorphone patch, oxycodone patch, tretinoin gel and transdermal opioid patches. The company also develops cannabinoid products in partnership with major drug manufacturers. It markets products under Vital ET and TPM brand names. It has business presence in Australia, India, Switzerland, and the US. Avecho is headquartered in Clayton, Victoria, Australia.\u003c\/p\u003e\n\n\u003cp\u003eScopeDetailed information on Avecho Biotechnology Ltd required for business and competitor intelligence needsA study of the major internal and external factors affecting Avecho Biotechnology Ltd in the form of a SWOT analysisAn in-depth view of the business model of Avecho Biotechnology Ltd including a breakdown and examination of key business segmentsIntelligence on Avecho Biotechnology Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisorsNews about Avecho Biotechnology Ltd, such as business expansion, restructuring, and contract winsLarge number of easy-to-grasp charts and graphs that present important data and key trendsReasons to buyGain understanding of Avecho Biotechnology Ltd and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.Assess Avecho Biotechnology Ltd as a prospective partner, vendor or supplier.Support sales activities by understanding your customers' businesses better.Stay up to date on Avecho Biotechnology Ltd's business structure, strategy and prospects.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 45 Pages \/ MCW16230254","offer_id":47647061082418,"sku":null,"price":210.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/avecho-biotechnology-ltd-strategy-swot-and-corporate-finance-report","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}